# Comstock Resources Inc: financial statements, quarterly

CRK · NYSE · CIK 23194 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crk.md) · [Financials](/companies/crk/financials.md) · [Filings](/companies/crk/filings.md) · [Insiders](/companies/crk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [377](/filings/0000950170-24-119429.md) | [411 d](/filings/0001193125-26-059001.md) | [336](/filings/0000950170-25-061651.md) | [247](/filings/0000950170-25-100824.md) | [304](/filings/0001193125-25-264450.md) | [367 d](/filings/0001193125-26-059001.md) | [513](/filings/0001193125-26-208551.md) | [470](/filings/0001193125-26-326260.md) | [450](/filings/0001193125-25-264450.md) | [787 d](/filings/0001193125-26-059001.md) | [587](/filings/0001193125-26-208551.md) | [353](/filings/0001193125-26-326260.md) |
| Operating income | $m | [47.3](/filings/0000950170-24-119429.md) | [50.8 d](/filings/0001193125-26-059001.md) | [(12.8)](/filings/0000950170-25-061651.md) | [(92.5)](/filings/0000950170-25-100824.md) | [(61.3)](/filings/0001193125-25-264450.md) | [(1.9) d](/filings/0001193125-26-059001.md) | [126](/filings/0001193125-26-208551.md) | [89.4](/filings/0001193125-26-326260.md) | [50.2](/filings/0001193125-25-264450.md) | [380 d](/filings/0001193125-26-059001.md) | [175](/filings/0001193125-26-208551.md) | [22.6](/filings/0001193125-26-326260.md) |
| Interest expense | $m | [43.6](/filings/0000950170-23-058075.md) | [47.9 d](/filings/0000950170-24-016532.md) | [49.6](/filings/0000950170-24-051815.md) | [51.9](/filings/0000950170-24-089131.md) | [54.5](/filings/0001193125-25-264450.md) | [54.6 d](/filings/0001193125-26-059001.md) | [54.8](/filings/0001193125-26-208551.md) | [55.2](/filings/0001193125-26-326260.md) | [56.7](/filings/0001193125-25-264450.md) | [56.1 d](/filings/0001193125-26-059001.md) | [53.1](/filings/0001193125-26-208551.md) | [55.0](/filings/0001193125-26-326260.md) |
| Income tax | $m | [3.6](/filings/0000950170-24-119429.md) | [6.2 d](/filings/0001193125-26-059001.md) | [(8.3)](/filings/0000950170-25-061651.md) | [(46.1)](/filings/0000950170-25-100824.md) | [(14.7)](/filings/0001193125-25-264450.md) | [(80.0) d](/filings/0001193125-26-059001.md) | [(143)](/filings/0001193125-26-208551.md) | [141](/filings/0001193125-26-326260.md) | [18.6](/filings/0001193125-25-264450.md) | [71.7 d](/filings/0001193125-26-059001.md) | [12.0](/filings/0001193125-26-208551.md) | [(2.8)](/filings/0001193125-26-326260.md) |
| Net income | $m | [14.7](/filings/0000950170-24-119429.md) | [108 d](/filings/0001193125-26-059001.md) | [(16.3)](/filings/0000950170-25-061651.md) | [(126)](/filings/0000950170-25-100824.md) | [(28.9)](/filings/0001193125-25-264450.md) | [(58.1) d](/filings/0001193125-26-059001.md) | [(121)](/filings/0001193125-26-208551.md) | [125](/filings/0001193125-26-326260.md) | [111](/filings/0001193125-25-264450.md) | [281 d](/filings/0001193125-26-059001.md) | [107](/filings/0001193125-26-208551.md) | [8.8](/filings/0001193125-26-326260.md) |
| Diluted EPS | $ per share | [0.05](/filings/0000950170-24-119429.md) | not reported | [(0.05)](/filings/0000950170-25-061651.md) | [(0.43)](/filings/0000950170-25-100824.md) | [(0.09)](/filings/0001193125-25-264450.md) | not reported | [(0.40)](/filings/0001193125-26-208551.md) | [0.44](/filings/0001193125-26-326260.md) | [0.40](/filings/0001193125-25-264450.md) | not reported | [0.38](/filings/0001193125-26-208551.md) | [0.03](/filings/0001193125-26-326260.md) |
| Basic EPS | $ per share | [0.05](/filings/0000950170-24-119429.md) | not reported | [(0.05)](/filings/0000950170-25-061651.md) | [(0.43)](/filings/0000950170-25-100824.md) | [(0.09)](/filings/0001193125-25-264450.md) | not reported | [(0.40)](/filings/0001193125-26-208551.md) | [0.45](/filings/0001193125-26-326260.md) | [0.40](/filings/0001193125-25-264450.md) | not reported | [0.38](/filings/0001193125-26-208551.md) | [0.03](/filings/0001193125-26-326260.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [19.8](/filings/0000950170-23-058075.md) | [16.7](/filings/0000950170-25-024783.md) | [6.4](/filings/0000950170-24-051815.md) | [19.3](/filings/0000950170-24-089131.md) | [13.8](/filings/0000950170-24-119429.md) | [6.8](/filings/0001193125-26-059001.md) | [32.9](/filings/0000950170-25-061651.md) | [25.9](/filings/0000950170-25-100824.md) | [19.2](/filings/0001193125-25-264450.md) | [23.9](/filings/0001193125-26-326260.md) | [14.8](/filings/0001193125-26-208551.md) | [45.0](/filings/0001193125-26-326260.md) |
| Current assets | $m | [327](/filings/0000950170-23-058075.md) | [461](/filings/0000950170-25-024783.md) | [358](/filings/0000950170-24-051815.md) | [323](/filings/0000950170-24-089131.md) | [300](/filings/0000950170-24-119429.md) | [284](/filings/0001193125-26-059001.md) | [339](/filings/0000950170-25-061651.md) | [269](/filings/0000950170-25-100824.md) | [269](/filings/0001193125-25-264450.md) | [361](/filings/0001193125-26-326260.md) | [290](/filings/0001193125-26-208551.md) | [339](/filings/0001193125-26-326260.md) |
| Total assets | $m | [6,031](/filings/0000950170-23-058075.md) | [6,254](/filings/0000950170-25-024783.md) | [6,317](/filings/0000950170-24-051815.md) | [6,325](/filings/0000950170-24-089131.md) | [6,313](/filings/0000950170-24-119429.md) | [6,382](/filings/0001193125-26-059001.md) | [6,602](/filings/0000950170-25-061651.md) | [6,695](/filings/0000950170-25-100824.md) | [6,841](/filings/0001193125-25-264450.md) | [7,007](/filings/0001193125-26-326260.md) | [7,240](/filings/0001193125-26-208551.md) | [7,525](/filings/0001193125-26-326260.md) |
| Current liabilities | $m | [660](/filings/0000950170-23-058075.md) | [681](/filings/0000950170-25-024783.md) | [556](/filings/0000950170-24-051815.md) | [552](/filings/0000950170-24-089131.md) | [500](/filings/0000950170-24-119429.md) | [613](/filings/0001193125-26-059001.md) | [858](/filings/0000950170-25-061651.md) | [748](/filings/0000950170-25-100824.md) | [650](/filings/0001193125-25-264450.md) | [730](/filings/0001193125-26-326260.md) | [712](/filings/0001193125-26-208551.md) | [712](/filings/0001193125-26-326260.md) |
| Total liabilities | $m | [3,748](/filings/0000950170-23-058075.md) | [3,870](/filings/0000950170-25-024783.md) | [3,839](/filings/0000950170-24-051815.md) | [3,959](/filings/0000950170-24-089131.md) | [3,951](/filings/0000950170-24-119429.md) | [4,049](/filings/0001193125-26-059001.md) | [4,324](/filings/0000950170-25-061651.md) | [4,260](/filings/0000950170-25-100824.md) | [4,223](/filings/0001193125-25-264450.md) | [4,044](/filings/0001193125-26-326260.md) | [4,169](/filings/0001193125-26-208551.md) | [4,361](/filings/0001193125-26-326260.md) |
| Long-term debt | $m | [2,503](/filings/0000950170-23-058075.md) | [2,640](/filings/0000950170-25-024783.md) | [2,702](/filings/0000950170-24-051815.md) | [2,856](/filings/0000950170-24-089131.md) | [2,949](/filings/0000950170-24-119429.md) | [2,952](/filings/0001193125-26-059001.md) | [3,050](/filings/0000950170-25-061651.md) | [3,018](/filings/0000950170-25-100824.md) | [3,126](/filings/0001193125-25-264450.md) | [2,809](/filings/0001193125-26-326260.md) | [2,948](/filings/0001193125-26-208551.md) | [3,099](/filings/0001193125-26-326260.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,283](/filings/0000950170-23-058075.md) | [2,358](/filings/0000950170-25-024783.md) | [2,446](/filings/0000950170-24-051815.md) | [2,320](/filings/0000950170-24-089131.md) | [2,295](/filings/0000950170-24-119429.md) | [2,241](/filings/0001193125-26-059001.md) | [2,121](/filings/0000950170-25-061651.md) | [2,244](/filings/0000950170-25-100824.md) | [2,360](/filings/0001193125-25-264450.md) | [2,647](/filings/0001193125-26-326260.md) | [2,757](/filings/0001193125-26-208551.md) | [2,579](/filings/0001193125-26-326260.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [70.8 d](/filings/0000950170-24-119429.md) | [228 d](/filings/0001193125-26-059001.md) | [172](/filings/0000950170-25-061651.md) | [83.6 d](/filings/0000950170-25-100824.md) | [98.2 d](/filings/0001193125-25-264450.md) | [267 d](/filings/0001193125-26-059001.md) | [175](/filings/0001193125-26-208551.md) | [348 d](/filings/0001193125-26-326260.md) | [153 d](/filings/0001193125-25-264450.md) | [224 d](/filings/0001193125-26-059001.md) | [272](/filings/0001193125-26-208551.md) | [170 d](/filings/0001193125-26-326260.md) |
| Capital expenditure | $m | [345 d](/filings/0000950170-24-119429.md) | [336 d](/filings/0001193125-26-059001.md) | [351](/filings/0000950170-25-061651.md) | [237 d](/filings/0000950170-25-100824.md) | [229 d](/filings/0001193125-25-264450.md) | [280 d](/filings/0001193125-26-059001.md) | [298](/filings/0001193125-26-208551.md) | [344 d](/filings/0001193125-26-326260.md) | [342 d](/filings/0001193125-25-264450.md) | [365 d](/filings/0001193125-26-059001.md) | [416](/filings/0001193125-26-208551.md) | [432 d](/filings/0001193125-26-326260.md) |
| Dividends paid | $m | [34.8 d](/filings/0000950170-24-119429.md) | [34.8 d](/filings/0001193125-26-059001.md) | [0.0](/filings/0000950170-24-051815.md) | [0.0 d](/filings/0000950170-24-089131.md) | [0.0 d](/filings/0000950170-24-119429.md) | [0.0 d](/filings/0001193125-26-059001.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [278](/filings/0000950170-23-058075.md) | [277](/filings/0000950170-24-051815.md) | [277](/filings/0000950170-24-089131.md) | [277](/filings/0000950170-24-119429.md) | [278](/filings/0000950170-25-061651.md) | [290](/filings/0000950170-25-100824.md) | [290](/filings/0001193125-25-264450.md) | [290](/filings/0001193125-26-208551.md) | [294](/filings/0001193125-26-326260.md) | [294](/filings/0001193125-25-264450.md) | [291](/filings/0001193125-26-208551.md) | [292](/filings/0001193125-26-326260.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 293,620,548 at 2026-07-29, from the cover of the [10-Q filed 2026-07-30](/filings/0001193125-26-326260.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.